Back to Directory
medical devices logo

Enable Injections, Inc. | Company Profile

10/3/2025

Contact Information

๐Ÿ‘ค
Enable Injections, Inc.
๐Ÿข
Enable Injections, Inc.
๐Ÿ“
2863 East Sharon Road, Cincinnati, Ohio 45241, US

Industry & Market

Primary Industry
medical devices
Location
Cincinnati, Ohio, United States

Company Metrics

๐Ÿ‘ฅTotal Employees
123
โš™๏ธEngineering
66
๐Ÿ’ผSales Team
N/A
๐Ÿ“ˆMarketing
1
๐Ÿ“…Founded
2010
๐Ÿ’ฐRevenue
24.8M

Funding Information

Total Funding
$345.0M
Latest Stage
Series c
Annual Revenue
$24,800,000

Headcount Distribution

Total Employees
123
Departments
19

By Department

Department Breakdown

Engineering
Information Technology
Finance
Accounting
Human Resources
Arts And Design
Others

Technology Stack

Email & Communication

Outlook
Total: 8 technologies

Keywords & Focus Areas

combination productpatientcentric technologysubcutaneous drug deliveryhighviscositywearable drug delivery devicelarge volume drug delivery deviceenfuseonbody infusorwearable injectorinjectordelivery systemdrug delivery systemmedical equipment manufacturingautomated mixing systemscombination therapy deliverypatient-centric drug deliveryautomated drug transfer systemssubcutaneous injectionlarge volume drug infusionsmart enfuse app+10 more
30 total keywords

Enable Injections, Inc.

Overview

Enable Injections, Inc. is a healthcare innovation company based in Cincinnati, Ohio, founded in 2010. The company specializes in developing and manufacturing advanced wearable drug delivery systems. Its flagship product, the enFuseยฎ on-body delivery platform, is a mechanical, hands-free injector designed to deliver large volumes of pharmaceutical and biologic therapeutics subcutaneously. This system allows patients to self-administer treatments that typically require intravenous infusion, enhancing convenience and comfort.

The enFuse system is compatible with standard drug container closures and features a discreet design with a hidden needle that retracts automatically after use. Enable Injections operates primarily through partnerships with pharmaceutical and biotechnology companies, generating revenue from development agreements, licensing, and manufacturing. The company has notable collaborations with major firms like Sanofi, Roche, and Apellis Pharmaceuticals. In September 2023, the enFuse device received FDA approval for use with Apellisโ€™ drug for paroxysmal nocturnal hemoglobinuria. With over $300 million raised in capital funding, Enable Injections is committed to improving patient experiences and reducing healthcare costs.

Basic Information

Industrymedical devices
Founded2010
Revenue24.8M
Headquarters2863 East Sharon Road, Cincinnati, Ohio 45241, United States

Contact Details

Key Focus Areas & Initiatives

  • Combination product
  • Patientcentric technology
  • Subcutaneous drug delivery
  • Highviscosity
  • Wearable drug delivery device
  • Large volume drug delivery device
  • Enfuse
  • Onbody infusor
  • Wearable injector
  • Injector
  • Delivery system
  • Drug delivery system
  • Medical equipment manufacturing
  • Automated mixing systems
  • Combination therapy delivery
  • Patient-centric drug delivery
  • Automated drug transfer systems
  • Subcutaneous injection
  • Large volume drug infusion
  • Smart enfuse app
  • Biologic viscosities support
  • Biologic and pharmaceutical compatibility
  • Patient safety
  • Medical devices
  • Patient adherence tracking
  • Patient self-administration
  • Discreet injection system
  • Medical device innovation
  • Patient experience enhancement
  • Large volume infusion
  • Medical device manufacturing
  • Bluetooth connectivity
  • Clinical development tools
  • Wearable drug delivery system
  • Disposable wearable injectors
  • Digital health integration
  • Cost reduction in drug delivery
  • Dual vial transfer system
  • Medical device patents
  • Pharmaceutical device compatibility
  • Automated fluid transfer
  • Hands-free injection technology
  • Pharmaceuticals
  • Remote patient monitoring
  • Clinical trial support
  • Drug reconstitution
  • Healthcare technology
  • FDA approved drug device
  • Wearable drug delivery
  • Enfuse platform
  • Custom needle design
  • Biologics delivery
  • Reconstitution automation
  • Self-administration in-home
  • Smart connected medical devices
  • B2B
  • B2C
  • D2C
  • Medical equipment and supplies manufacturing
  • Medical technology
  • Life sciences
  • Hospital & health care
  • Medical

Technologies Used

  • CloudFlare
  • Cloudflare DNS
  • Microsoft Azure
  • Mimecast
  • Outlook
  • Pardot
  • Remote
  • WP Engine

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Try Bitscale Now

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

SayData

ยฉ 2025 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube